Biotechnology Value Fund L P - Jun 30, 2025 SCHEDULE 13G/A Report for CRESCENT BIOPHARMA, INC. Ordinary Shares, $0.001 par value per share (CBIO)

Filing Manager
BIOTECHNOLOGY VALUE FUND L P
Reporting Manager
BVF PARTNERS L P/IL
Security
CRESCENT BIOPHARMA, INC. Ordinary Shares, $0.001 par value per share
Symbol
CBIO
Shares outstanding
13.9M shares
Disclosed Ownership
1.39M shares
Ownership
9.99%
Form type
SCHEDULE 13G/A
Date filed
8/14/2025, 04:01 PM
Date of event
Jun 30, 2025
SEC
View on sec.gov

Reporting Managers (10)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
BIOTECHNOLOGY VALUE FUND L P 5.1% 707K 0 707K /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF I GP LLC 5.1% 707K 0 707K /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BIOTECHNOLOGY VALUE FUND II LP 4.3% 594K 0 594K /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF II GP LLC 4.3% 594K 0 594K /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
Biotechnology Value Trading Fund OS LP 0.4% 62.4K 0 62.4K /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF Partners OS Ltd. 0.4% 62.4K 0 62.4K /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF GP HOLDINGS LLC 9.4% 1.3M 0 1.3M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF PARTNERS L P/IL 9.99% 1.39M 0 1.39M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF INC/IL 9.99% 1.39M 0 1.39M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
LAMPERT MARK N 9.99% 1.39M 0 1.39M /s/ Mark N. Lampert Mark N. Lampert